Establishment of a Pediatric COVID-19 Biorepository

The global pandemic of COVID-19, caused by the highly infectious and transmissible coronavirus, SARS-CoV-2, has become a leading cause of death in older adults. While adults can develop life-threatening complications such as pneumonia, acute respiratory distress syndrome (ARDS), and sepsis from SARS-CoV-2 infection, its impact on children is less clinically apparent and needs to be studied.

Although children were initially felt to be spared from COVID-19, it has become clear that much needs to be learned as to how children and newborns are impacted by the pandemic. Research is needed to address:

  1. Viral transmission by children
  2. Differences in pediatric viral susceptibility and immune responses
  3. The impact of maternal SARS-CoV-2 infection on fetal development and
  4. Factors driving the MIS-C

The Pediatric COVID-19 Biorepository will serve as an important resource providing critical insight into disease pathogenesis, COVID-19-susceptibility, and future treatment and vaccination strategies.

Click here to read more.

    The Features PDF has been emailed to you.
    Feel free to "Schedule a Demo" or "Contact Us" for any questions.

    Srikanth Adiga,
    C.E.0, OpenSpecimen
    Email: sri@krishagni.com


        Avoid Gmail, Yahoo, etc. please.

          The 'OpenSpecimen Biobanking LIMS RFP Q&A' Excel is emailed to you.
          Feel free to Contact Us for any questions.

          Srikanth Adiga,
          C.E.0, OpenSpecimen
          Email: sri@krishagni.com